<DOC>
	<DOCNO>NCT01225315</DOCNO>
	<brief_summary>This study ass efficacy safety ACT-129968 subject partly control asthma reliever therapy .</brief_summary>
	<brief_title>Study ACT-129968 Adult Patients With Partly Controlled Asthma .</brief_title>
	<detailed_description />
	<mesh_term>Asthma</mesh_term>
	<mesh_term>Albuterol</mesh_term>
	<criteria>Males female age 18 65 year Presenting diagnosis asthma accord GINA Guidelines Prebronchodilator force expiratory volume one second ( FEV1 ) &lt; / = 85 % patient 's predict normal value Reversibility airway obstruction &gt; / = 12 % &gt; / = 200mL prebronchodilator FEV1 ACQ score &gt; / = 1.5 History lifethreatening asthma Any asthma exacerbation require treatment systemic corticosteroid within last 3 month Ongoing recent treatment medication allergic airway disease Smoking within last year , lifetime consumption &gt; / = 10 packyears ( e.g. , 20 cigarettes/day 10 year ) History chronic pulmonary disease ( asthma ) , chronic obstructive pulmonary disease ( COPD ) , fibrosis , tuberculosis sarcoidosis</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>June 2013</verification_date>
</DOC>